351 related articles for article (PubMed ID: 17785848)
1. Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria.
Lepenies B; Pfeffer K; Hurchla MA; Murphy TL; Murphy KM; Oetzel J; Fleischer B; Jacobs T
J Immunol; 2007 Sep; 179(6):4093-100. PubMed ID: 17785848
[TBL] [Abstract][Full Text] [Related]
2. B and T lymphocyte attenuator restricts the protective immune response against experimental malaria.
Adler G; Steeg C; Pfeffer K; Murphy TL; Murphy KM; Langhorne J; Jacobs T
J Immunol; 2011 Nov; 187(10):5310-9. PubMed ID: 21998455
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.
Villegas-Mendez A; Greig R; Shaw TN; de Souza JB; Gwyer Findlay E; Stumhofer JS; Hafalla JC; Blount DG; Hunter CA; Riley EM; Couper KN
J Immunol; 2012 Jul; 189(2):968-79. PubMed ID: 22723523
[TBL] [Abstract][Full Text] [Related]
4. Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation.
Hurchla MA; Sedy JR; Murphy KM
J Immunol; 2007 May; 178(10):6073-82. PubMed ID: 17475832
[TBL] [Abstract][Full Text] [Related]
5. Suppression of CD4+ Effector Responses by Naturally Occurring CD4+ CD25+ Foxp3+ Regulatory T Cells Contributes to Experimental Cerebral Malaria.
Blanc AL; Keswani T; Gorgette O; Bandeira A; Malissen B; Cazenave PA; Pied S
Infect Immun; 2016 Jan; 84(1):329-38. PubMed ID: 26553468
[TBL] [Abstract][Full Text] [Related]
6. Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants.
del Rio ML; Kaye J; Rodriguez-Barbosa JI
Immunobiology; 2010 Jul; 215(7):570-8. PubMed ID: 19837478
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.
Campanella GS; Tager AM; El Khoury JK; Thomas SY; Abrazinski TA; Manice LA; Colvin RA; Luster AD
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4814-9. PubMed ID: 18347328
[TBL] [Abstract][Full Text] [Related]
8. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
9. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.
Miyakoda M; Kimura D; Yuda M; Chinzei Y; Shibata Y; Honma K; Yui K
J Immunol; 2008 Jul; 181(2):1420-8. PubMed ID: 18606696
[TBL] [Abstract][Full Text] [Related]
10. T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway.
Rodriguez-Barbosa JI; Fernandez-Renedo C; Moral AMB; Bühler L; Del Rio ML
Cell Mol Immunol; 2017 Jun; 14(6):497-510. PubMed ID: 26924526
[TBL] [Abstract][Full Text] [Related]
11. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
[TBL] [Abstract][Full Text] [Related]
12. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis.
Nitcheu J; Bonduelle O; Combadiere C; Tefit M; Seilhean D; Mazier D; Combadiere B
J Immunol; 2003 Feb; 170(4):2221-8. PubMed ID: 12574396
[TBL] [Abstract][Full Text] [Related]
13. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
14. NK cells and conventional dendritic cells engage in reciprocal activation for the induction of inflammatory responses during Plasmodium berghei ANKA infection.
Ryg-Cornejo V; Nie CQ; Bernard NJ; Lundie RJ; Evans KJ; Crabb BS; Schofield L; Hansen DS
Immunobiology; 2013 Feb; 218(2):263-71. PubMed ID: 22704523
[TBL] [Abstract][Full Text] [Related]
15. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA.
Randall LM; Amante FH; Zhou Y; Stanley AC; Haque A; Rivera F; Pfeffer K; Scheu S; Hill GR; Tamada K; Engwerda CR
J Immunol; 2008 Dec; 181(11):7458-62. PubMed ID: 19017933
[TBL] [Abstract][Full Text] [Related]
18. Development of a Novel CD4
Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
[TBL] [Abstract][Full Text] [Related]
20. Murine malaria is exacerbated by CTLA-4 blockade.
Jacobs T; Graefe SE; Niknafs S; Gaworski I; Fleischer B
J Immunol; 2002 Sep; 169(5):2323-9. PubMed ID: 12193697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
